Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Iobenguane I-131 in Treating Patients with Recurrent Neuroblastoma, Malignant Pheochromocytoma, or Malignant Paraganglioma

Trial Status: active

This phase II trial studies the side effects of targeted radiation therapy with iobenguane I-131 and to see how well it works in treating patients with neuroblastoma that has come back or has not responded to treatment, or pheochromocytoma or paraganglioma that has spread to other places in the body. Radioactive drugs, such as iobenguane I-131, may carry radiation directly to tumor cells and not harm normal cells.